SCF ENCYCLOPEDIA ENTRY

MASTITIS

1. SCOPE & POSITIONING

Etiology / Classification

Mastitis is an inflammatory disorder of the breast, most commonly occurring during lactation but also occurring in non-lactating individuals. It may be:

• Infectious mastitis
• Non-infectious inflammatory mastitis
• Lactational mastitis
• Periductal mastitis
• Granulomatous mastitis
• Recurrent mastitis

SCF Classification

SCF Domain: Maternal–Infant Health / Infectious Disease / Inflammatory Disorders / Lactation Medicine

SCF Disease Class:

Maternal Mammary Gland Inflammatory–Infectious Synchronization Failure Syndrome

Clinical Significance

Mastitis is among the most common breastfeeding complications and may result in:

• Severe breast pain
• Reduced milk production
• Lactation failure
• Breast abscess formation
• Premature cessation of breastfeeding
• Maternal systemic infection

SCF Domain Alignment

Primary Systems:

• Mammary gland
• Immune system
• Lymphatic system
• Endocrine system
• Maternal–infant nutritional transfer system

2. ETIOPATHOGENIC CORE

Primary Cause

Mastitis develops when milk stasis, ductal obstruction, tissue injury, microbial invasion, or inflammatory dysregulation disrupt normal mammary gland homeostasis.

Key Drivers

Mechanical Drivers

• Incomplete breast emptying
• Poor infant latch
• Infrequent feeding
• Duct obstruction

Infectious Drivers

Most common pathogen:

• Staphylococcus aureus

Other organisms:

• Coagulase-negative staphylococci
• Streptococci
• Methicillin-resistant S. aureus (MRSA)

Host Factors

• Nipple trauma
• Maternal fatigue
• Immune stress
• Previous mastitis

3. SCF FAULT ARCHITECTURE

4. PATHOGENESIS FLOW (SCF LOGIC)

Stage 1 — Milk Flow Disruption

Contributors:

• Poor drainage
• Feeding irregularity
• Duct compression

↓

Stage 2 — Intraductal Pressure Elevation

Results in:

• Alveolar distention
• Tissue stress
• Local inflammation

↓

Stage 3 — Mammary Barrier Breakdown

Produces:

• Increased permeability
• Tissue injury
• Immune activation

↓

Stage 4 — Inflammatory Amplification

Includes:

• Cytokine release
• Leukocyte infiltration
• Edema formation

↓

Stage 5 — Infection (when present)

Pathogens enter through:

• Nipple fissures
• Skin defects
• Ductal structures

↓

Stage 6 — Functional Consequences

Results in:

• Pain
• Reduced milk transfer
• Lactation impairment
• Abscess formation

5. CLINICAL SPECTRUM

6. SCF TRINITY FRAMEWORK MAPPING

STRUCTURAL DOMAIN

Affected Structures:

• Mammary ducts
• Alveoli
• Nipple epithelium
• Breast connective tissue

FUNCTIONAL DOMAIN

Affected Functions:

• Milk synthesis
• Milk ejection
• Nutritional transfer
• Local immune defense

INFORMATIONAL DOMAIN

Affected Signaling Systems:

• Prolactin pathways
• Oxytocin signaling
• Cytokine networks
• Neuroendocrine feedback loops

7. SCF PCR THERAPEUTIC STRATEGY

PREVENTATIVE

Lactation Optimization

• Proper latch education
• Frequent milk removal
• Nipple care
• Breastfeeding support

Risk Reduction

• Early management of engorgement
• Avoid prolonged milk stasis
• Maternal rest and hydration

CURATIVE

Mechanical Correction

• Continue breastfeeding when appropriate
• Pumping assistance
• Duct decompression

Anti-Inflammatory Management

Common agents:

• Ibuprofen

Antimicrobial Therapy

Common therapies include:

• Dicloxacillin
• Cephalexin

For resistant organisms:

• Clindamycin
• Trimethoprim-Sulfamethoxazole

Abscess Management

May require:

• Ultrasound-guided drainage
• Surgical drainage

Associated with:

• Breast Abscess

RESTORATIVE

Recovery Objectives

• Restore milk production
• Normalize breast drainage
• Prevent recurrence
• Maintain breastfeeding success

8. CURRENT STANDARD OF CARE

Standard management includes:

1. Continued breast emptying
2. Breastfeeding support
3. Pain control
4. Appropriate antibiotics when infection is suspected
5. Ultrasound evaluation for abscess
6. Drainage of collections when necessary

9. SCF THERAPEUTIC ENGINEERING OPPORTUNITIES

Mammary Biofilm Control Systems

Potential targets:

• Staphylococcal biofilms
• Ductal microbial persistence

Lactation Preservation Therapeutics

Potential approaches:

• Ductal anti-inflammatory agents
• Mammary barrier stabilizers

Immune-Modulation Platforms

Targets:

• TNF-α
• IL-1β
• IL-6
• NF-κB pathways

Microbiome Engineering

Potential interventions:

• Mammary microbiome restoration
• Probiotic-assisted recovery

10. TRANSLATIONAL BLUEPRINT

Molecular Targets

Inflammatory Targets

• NF-κB
• IL-6
• IL-1β
• TNF-α

Barrier Integrity Targets

• Tight junction proteins
• Mammary epithelial repair pathways

Antimicrobial Targets

• Bacterial adhesion systems
• Biofilm formation pathways

Lactation Targets

• Prolactin receptor signaling
• Oxytocin-mediated milk ejection

11. SCF DBI INTERPRETATION

Under the SCF Decentralized Biological Intelligence (DBI) framework, mastitis represents failure of the maternal–infant nutrient-transfer network.

Disrupted systems include:

• Mammary communication networks
• Nutritional allocation pathways
• Local immune surveillance systems
• Neuroendocrine lactation coordination

DBI Signature:

Resource Accumulation → Network Congestion → Inflammatory Response → Functional Transfer Failure

The disease reflects a breakdown in biologic flow management rather than solely infection.

12. SCF LAYMAN’S SUMMARY

Mastitis occurs when breast milk becomes trapped or breast tissue becomes inflamed, often during breastfeeding. The trapped milk causes swelling and pain, and bacteria may sometimes enter the breast through damaged skin.

Common symptoms include:

• Breast pain
• Redness
• Swelling
• Fever
• Flu-like illness

Most cases improve with:

• Continued breastfeeding or milk removal
• Rest
• Hydration
• Anti-inflammatory medications
• Antibiotics when needed

Early treatment prevents serious complications such as breast abscesses and helps preserve successful breastfeeding.

13. MASTER REGISTRY INDEX

SCF-MAST-0001 — Mastitis

SCF-MAST-DUCT-0002 — Milk Stasis & Duct Obstruction Layer

SCF-MAST-INFLAMM-0003 — Mammary Inflammatory Activation Layer

SCF-MAST-INFECT-0004 — Infectious Mastitis Module

SCF-MAST-LACT-0005 — Lactation Dysfunction Layer

SCF-MAST-ABSCESS-0006 — Breast Abscess Progression Layer

SCF-MAST-DBI-0007 — Maternal–Infant Nutrient Transfer Disruption Layer

SCF-MAST-PCR-0008 — Preventative–Curative–Restorative Management Framework

Activated Adaptive Modules

✅ Infectious Disease Module

✅ Maternal–Infant Health Module

✅ Inflammatory Disease Module

✅ Lactation Medicine Module

✅ Pediatric Variant Module (Breastfeeding Dyad Considerations)